ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,215
Screening encounters
2,403
Diagnostic referrals
462
Outstanding pathways
195

Screening pathway

  1. Screening2,403Encounters
  2. Positive finding805Documented findings
  3. Referral462Diagnostic referrals
  4. Follow-up515Diagnostic visits
  5. Outcome267Resolved pathways

Stage totals use different units. Pending pathways: 195. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3308 · EXP-3308Synthetic · Site D

Full participant history through 2026-01-26, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · LSIL · Adequate
  3. · Diagnostic referral · EXP-3308-T-R
  4. · Contact attempt · Reached
  5. · Diagnostic booking · Initial booking
  6. · Barrier documented · Contact difficulty
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-07-16
  11. · Follow-up disposition · Resolved · EXP-3308-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2215 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3026 · Expanded synthetic participant 3026Site B — Peri-Urban Access Programme
EXP-3027 · Expanded synthetic participant 3027Site C — Rural Outreach Programme
EXP-3029 · Expanded synthetic participant 3029Site D — Community Engagement Programme
EXP-3030 · Expanded synthetic participant 3030Site C — Rural Outreach Programme
EXP-3033 · Expanded synthetic participant 3033Site C — Rural Outreach Programme
EXP-3035 · Expanded synthetic participant 3035Site A — Urban Referral Hub
EXP-3041 · Expanded synthetic participant 3041Site B — Peri-Urban Access Programme
EXP-3044 · Expanded synthetic participant 3044Site D — Community Engagement Programme
EXP-3047 · Expanded synthetic participant 3047Site B — Peri-Urban Access Programme
EXP-3049 · Expanded synthetic participant 3049Site D — Community Engagement Programme
EXP-3053 · Expanded synthetic participant 3053Site D — Community Engagement Programme
EXP-3054 · Expanded synthetic participant 3054Site C — Rural Outreach Programme
EXP-3057 · Expanded synthetic participant 3057Site D — Community Engagement Programme
EXP-3060 · Expanded synthetic participant 3060Site A — Urban Referral Hub
EXP-3062 · Expanded synthetic participant 3062Site E — Resource-Constrained Navigation Programme
EXP-3063 · Expanded synthetic participant 3063Site E — Resource-Constrained Navigation Programme
EXP-3066 · Expanded synthetic participant 3066Site E — Resource-Constrained Navigation Programme
EXP-3068 · Expanded synthetic participant 3068Site E — Resource-Constrained Navigation Programme
EXP-3071 · Expanded synthetic participant 3071Site D — Community Engagement Programme
EXP-3074 · Expanded synthetic participant 3074Site D — Community Engagement Programme
EXP-3079 · Expanded synthetic participant 3079Site A — Urban Referral Hub
EXP-3081 · Expanded synthetic participant 3081Site A — Urban Referral Hub
EXP-3082 · Expanded synthetic participant 3082Site D — Community Engagement Programme
EXP-3083 · Expanded synthetic participant 3083Site A — Urban Referral Hub
EXP-3086 · Expanded synthetic participant 3086Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1008
HPV DNA
1037
Cytology
358

Navigation activity

Barrier documented
397
Contact attempt
679
Navigation intervention
164
Diagnostic booking
572
Diagnostic visit
515

Documented barriers

Contact difficulty
125
Transport difficulty
133
Appointment coordination
139

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.